Literature DB >> 11171777

Implementation of strategies to control antimicrobial resistance.

R Murthy1.   

Abstract

Antimicrobial resistance has emerged as a major public health issue in recent years. A steady increase in resistance continues despite the introduction of new antibiotics, and resistant bacteria have been associated with increased patient morbidity and mortality as well as with increased costs. Addressing the problem of antimicrobial resistance requires both infection control and regulation of antibiotic use; addressing either alone is insufficient. Mounting evidence shows that control of the use of broad-spectrum antibiotics (especially vancomycin and third-generation cephalosporins) and implementation of infection control measures can result in decreased incidence of antibiotic-resistant bacteria such as vancomycin-resistant enterococci and extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella. Recent reports from professional organizations and a consensus of experts have outlined strategies for the control of resistance in hospitals, with specific measures identified for antibiotic control and infection control. These reports have emphasized the importance of a multidisciplinary approach in tackling this problem in hospitals and have suggested that a quality-improvement model be used to address antimicrobial resistance. A close collaboration among the disciplines of infectious diseases, microbiology, hospital epidemiology, pharmacy, and nursing, with particular emphasis in ICUs, and with strong support from hospital leadership, can result in an effective program that can be readily incorporated into the quality-improvement goals of any health-care organization.

Entities:  

Mesh:

Year:  2001        PMID: 11171777     DOI: 10.1378/chest.119.2_suppl.405s

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  6 in total

1.  Continuous vs. intermittent cefotaxime administration in patients with chronic obstructive pulmonary disease and respiratory tract infections: pharmacokinetics/pharmacodynamics, bacterial susceptibility and clinical efficacy.

Authors:  A R H van Zanten; M Oudijk; M K E Nohlmans-Paulssen; Y G van der Meer; A R J Girbes; K H Polderman
Journal:  Br J Clin Pharmacol       Date:  2006-07-21       Impact factor: 4.335

2.  2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Health Care Settings.

Authors:  Jane D Siegel; Emily Rhinehart; Marguerite Jackson; Linda Chiarello
Journal:  Am J Infect Control       Date:  2007-12       Impact factor: 2.918

3.  Aerobic Gram-negative Bacillary Pneumonia.

Authors:  Stephen Parodi; Matthew Bidwell Goetz
Journal:  Curr Infect Dis Rep       Date:  2002-06       Impact factor: 3.725

4.  The Appropriateness of Empiric Treatment of Urinary Tract Infections in a Tertiary Teaching Hospital in Joran: A Cross-Sectional Study.

Authors:  Rama Alkhawaldeh; Rana Abu Farha; Khawla Abu Hammour; Eman Alefishat
Journal:  Antibiotics (Basel)       Date:  2022-05-06

5.  Point-prevalence surveys of antimicrobial consumption and resistance at a paediatric and an adult tertiary referral hospital in Yangon, Myanmar.

Authors:  Win Thandar Oo; Samuel D Carr; Christian S Marchello; Moe Moe San; Aung Tun Oo; Khine Mar Oo; Kay Thi Lwin; Hla Hla Win; John A Crump
Journal:  Infect Prev Pract       Date:  2021-12-11

6.  Extended-spectrum β-lactamases producing Klebsiella pneumoniae isolated in two hospitals in Goiânia/Brazil: detection, prevalence, antimicrobial susceptibility and molecular typing.

Authors:  Daniella Fabíola Dos Santos; Fabiana Cristina Pimenta; Rodrigo Alves; Edlaine Rodrigues Montalvão; Daniela Braz Dos Santos; José Rodrigues do Carmo Filho
Journal:  Braz J Microbiol       Date:  2008-12-01       Impact factor: 2.476

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.